Aspiriant LLC’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
2,689
+86
+3% +$49.6K 0.03% 147
2026
Q1
$1.78M Buy
+2,603
New +$1.8M 0.05% 120
2024
Q2
Sell
-431
Closed -$206K 317
2024
Q1
$206K Hold
431
0.01% 306
2023
Q4
$202K Sell
431
-207
-32% -$97K 0.01% 299
2023
Q3
$281K Buy
+638
New +$280K 0.01% 235
2023
Q1
Sell
-435
Closed -$237K 289
2022
Q4
$237K Buy
+435
New +$227K 0.01% 241

Other funds holding NOC

Aspiriant LLC's NOC Position: Q2 2026 in Review

Aspiriant LLC increased its Northrop Grumman (NOC) stake by 3.3% in Q2 2026, buying an estimated $49.6K and bringing the position to 2,689 shares worth $1.37M. The position accounts for 0.03% of the portfolio, ranked #147.

Aspiriant LLC first reported a position in NOC in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.78M in Q1 2026. 1,811 funds tracked by Wall St. Rank hold NOC as of Q2 2026.

  • Aspiriant LLC held 2,689 shares of Northrop Grumman worth $1.37M as of Q2 2026.
  • Aspiriant LLC bought 86 Northrop Grumman shares in Q2 2026, an estimated $49.6K.
  • Northrop Grumman made up 0.03% of Aspiriant LLC's portfolio in Q2 2026, its #147 holding.
  • Aspiriant LLC first reported a position in Northrop Grumman in Q4 2022 and has held it in 6 quarters since.
  • Aspiriant LLC's Northrop Grumman position peaked at $1.78M in Q1 2026.
  • 1,811 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.